tiprankstipranks
Nanobiotix Sa ADR Updates Share Capital Info
PremiumCompany AnnouncementsNanobiotix Sa ADR Updates Share Capital Info
17d ago
Voting Rights and Shares Capital of the Company
PremiumPress Releases
Voting Rights and Shares Capital of the Company
17d ago
Nanobiotix Advances NBTXR3 for Lung Cancer Treatment
PremiumCompany Announcements
Nanobiotix Advances NBTXR3 for Lung Cancer Treatment
25d ago
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
PremiumPress ReleasesNanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
3M ago
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
PremiumPress Releases
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
3M ago
Nanobiotixachieves $20M milestone payment from Johnson & Johnson subsidiary
PremiumThe Fly
Nanobiotixachieves $20M milestone payment from Johnson & Johnson subsidiary
3M ago
Nanobiotix initiated with an Outperform at Leerink
PremiumThe FlyNanobiotix initiated with an Outperform at Leerink
5M ago
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
PremiumPress Releases
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
5M ago
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
PremiumPress Releases
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100